Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol.

ABSTRACT:

Introduction

Globally, rheumatic heart disease (RHD) is an important cause of acquired heart disease in children and adolescents. Clinical trials on RHD treatment with Traditional Chinese Medicine (TCM) or integrated medicine are gradually increasing in China. However, because the outcomes of clinical trials are subject to heterogeneity and selective reporting, similar studies cannot be merged and compared, complicating assessing the effectiveness and safety of TCM, and diminishing the value of clinical trials. Therefore, there is an urgent need to design a TCM or integrated medicine core outcome set (COS) for RHD.

Methods and analysis

The development of this study will take place in four stages under the direction of a multidisciplinary advisory board. (1) Establishing a co

SUBMITTER: Sheng X 

PROVIDER: S-EPMC9660565 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature